790
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Prognostic Factors Associated with Survival After Breast Cancer Recurrence

&
Pages 583-586 | Received 05 Mar 1990, Accepted 15 Oct 1990, Published online: 08 Jul 2009
 

Abstract

Factors associated with disease-free interval after the primary treatment and survival after a recurrence of breast cancer were studied in 331 female breast cancer patients treated in 1976 1980. Within five years after the primary treatment, recurrence occurred in 131 patients. the observation time of these patients after recurrence was from few weeks to twelve years. Twenty-nine patients were alive at the end of the follow-up. the average disease-free time was 2 years. the clinical stage of the disease in this material was not significantly associated with the disease-free interval. the median survival time after recurrence was 2.7 years when only breast cancer related deaths were included. Survival was significantly better for patients with primarily stage I disease than for patients with primarily stage II-IV disease. the size of the primary tumour was not significantly associated with survival after recurrence. the patients with loco-regional recurrence survived almost significantly better than those with distant recurrence. the disease-free time correlated positively with survival after a recurrence. the present study confirms the view that breast cancer includes several subgroups with a different type of clinical course.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.